Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
983 studies found for:    Open Studies | "Colorectal Neoplasms"
Show Display Options
Rank Status Study
21 Not yet recruiting Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 and an Target Therapy in First Line Treatment of Metastic Colorectal Cancer Restricted to the Liver
Condition: Colorectal Neoplasms
Interventions: Drug: Oxaliplatin intravenous;   Drug: 5 Fu;   Drug: Folinic Acid;   Drug: Oxaliplatin intra-arteriel;   Drug: Panitumumab;   Drug: Bevacizumab
22 Recruiting A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: KD018;   Drug: Irinotecan;   Drug: Placebo
23 Recruiting Epidemiological and Molecular Colorectal Cancer Registry
Conditions: Colorectal Neoplasms;   Colorectal Cancer
Intervention:
24 Recruiting Modufolin® in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
Condition: Colorectal Neoplasm
Interventions: Drug: Modufolin;   Drug: Fluorouracil;   Drug: Oxaliplatin;   Drug: Irinotecan
25 Recruiting Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
Condition: Colorectal Neoplasms
Interventions: Device: SIR-Spheres;   Drug: Regorafenib
26 Recruiting Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers
Condition: Colorectal Neoplasms
Intervention: Drug: Entecavir
27 Not yet recruiting Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Condition: Colorectal Neoplasms, Hereditary Nonpolyposis
Interventions: Drug: Mesalamine 1600 mg QD;   Drug: Mesalamine 3200 mg QD;   Drug: Placebo
28 Recruiting Regorafenib Post-marketing Surveillance
Condition: Colorectal Neoplasms
Intervention: Drug: BAY73-4506_Regorafenib
29 Recruiting Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study
Condition: Colorectal Cancer
Intervention:
30 Not yet recruiting Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor
Condition: Colorectal Tumor
Intervention: Device: Transanal Tube Drainage
31 Recruiting A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: panitumumab, TAS-102
32 Recruiting Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial
Condition: Colorectal Cancer
Intervention: Behavioral: Active Arm #1, #2, Passive Arm #1, #2
33 Not yet recruiting Use of ctDNA for Monitoring of Stage III Colorectal Cancer
Condition: Stage III Colorectal Cancer
Intervention:
34 Recruiting Familial Colorectal Cancer Registry in Hispanics
Condition: Colorectal Cancer
Intervention:
35 Recruiting Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network
Condition: Colorectal Neoplasm
Intervention: Device: cap-assisted chromoendoscopy
36 Recruiting Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Sym004;   Drug: Irinotecan;   Drug: Folinic Acid;   Drug: Fluorouracil
37 Recruiting Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Bevacizumab plus alternating Xelox/Xeliri
38 Recruiting A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland
Condition: Metastatic Colorectal Cancer
Intervention: Other: Biomarker sampling
39 Not yet recruiting Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy
Condition: Colorectal Cancer
Intervention: Drug: Niclosamide
40 Recruiting Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: TAS-102 and Bevacizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.